MYND Life Sciences Inc. (CSE:MYND)

Canada flag Canada · Delayed Price · Currency is CAD
0.0500
-0.0250 (-33.33%)
Feb 14, 2025, 4:00 PM EST
66.67%
Market Cap 2.39M
Revenue (ttm) 1.00
Net Income (ttm) -542.57K
Shares Out 47.82M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 15,432
Average Volume 1,420
Open 0.0750
Previous Close 0.0750
Day's Range 0.0500 - 0.0750
52-Week Range 0.0100 - 0.1400
Beta 1.33
RSI 23.94
Earnings Date Feb 28, 2025

About MYND Life Sciences

MYND Life Sciences Inc., a life sciences-based neuro-pharmaceutical drug development company, advances medicines based on neuro-anti-inflammatory substances for depressive disorders through science and clinical trials in Canada and the United States. It focuses on the analysis of psilocin and psilocybin extracts, and analogs. MYND Life Sciences Inc. is based in Port Coquitlam, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
CEO John Campbell
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol MYND
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.